Unknown OBSERVATIONAL NCT06272929

Serum Elafin and Vascular Affection in Behcet Disease

Serum Elafin: A Biomarker in Behcet Disease and Its Relation to Vascular Involvement and Disease Activity

Sponsor: Assiut University

Conditions Behcet Disease and Vascular Affection

Updated 4 times since 2024 Last updated: Feb 16, 2024 Started: Mar 1, 2024 Primary completion: Mar 1, 2025 Completion: Apr 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Behcet Disease and Vascular Affection, this trial is ongoing. The trial is conducted by Assiut University and has accumulated 4 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Mar 2026 — Present [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Mar 2026 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Mar 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.